Protagonist Therapeutics, Inc. (PTGX)

USD 39.02

(-4.1%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 357.95 Million 247.92 Million 347.69 Million 324.46 Million 154.91 Million 139.47 Million
Total Current Assets 355.57 Million 237.35 Million 340.73 Million 315.6 Million 145.31 Million 137.5 Million
Cash And Short Term Investments 341.61 Million 237.35 Million 326.9 Million 307.8 Million 133.01 Million 128.85 Million
Cash and Cash Equivalents 186.72 Million 125.74 Million 123.66 Million 117.35 Million 33 Million 82.23 Million
Short Term Investments 154.89 Million 111.61 Million 203.23 Million 188.45 Million 100.01 Million 46.62 Million
Net Receivables 10.33 Million 52 Thousand 4.35 Million 3.51 Million 6.75 Million 6.01 Million
Inventory -10.33 Million -94 Thousand 8.5 Million 3.97 Million 4.79 Million 2.13 Million
Other Current Assets 13.96 Million 42 Thousand 975 Thousand 311 Thousand 744 Thousand 495 Thousand
Total Non-Current Assets 2.37 Million 10.57 Million 6.95 Million 8.86 Million 9.6 Million 1.96 Million
Net PPE 2.14 Million 4.62 Million 6.73 Million 6.41 Million 7.72 Million 861 Thousand
Good Will And Intangible Assets -446 Thousand - - -1.04 Million -450 Thousand -450 Thousand
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 225 Thousand 225 Thousand 225 Thousand 2 Million 450 Thousand 450 Thousand
Tax Assets 221 Thousand - - 1.04 Million 1.43 Million 658 Thousand
Other Non Current Assets 225 Thousand 5.72 Million - 450 Thousand 450 Thousand 450 Thousand
Other Assets - - - - - -
Total Liabilities 21.27 Million 784.68 Million 47.67 Million 44.86 Million 74.95 Million 26.95 Million
Total Current Liabilities 21.27 Million 31.17 Million 44.01 Million 40.24 Million 35.4 Million 26.15 Million
Account Payables 772 Thousand 3.64 Million 1.6 Million 3.07 Million 2.79 Million 5.71 Million
Tax Payables - - - - - -
Short Term Debt 1.14 Million 2.51 Million 2.2 Million 1.45 Million 1.25 Million 1.06 Million
Deferred Revenue 3000.00 69 Thousand 1.6 Million 14.47 Million 41.53 Million 8.22 Million
Other Current Liabilities 19.35 Million 24.95 Million 38.61 Million 21.23 Million -10.17 Million 11.16 Million
Total Non Current Liabilities 221 Thousand 784.68 Million 3.65 Million 4.62 Million 39.54 Million 799 Thousand
Long-Term Debt - 1.14 Million 3.65 Million 4.5 Million 15.75 Million -
Deferred Revenue Non Current - - - -1.04 Million 23.79 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 783.54 Million - 121 Thousand -1.26 Million 799 Thousand
Other Liabilities -221 Thousand -31.17 Million - - - -
Total Equity 336.67 Million -536.75 Million -409.36 Million -283.81 Million -217.66 Million -140.47 Million
Stock Holders Equity 336.67 Million -536.75 Million -409.36 Million -283.81 Million -217.66 Million -140.47 Million
Common Stock 1000.00 - - - - -
Retained Earnings -615.71 Million -536.75 Million -409.36 Million -283.81 Million -217.66 Million -140.47 Million
Accumulated other comprehensive income -105 Thousand -359 Thousand -299 Thousand 28 Thousand -221 Thousand -233 Thousand
Common Stock Equity 336.67 Million -536.75 Million -409.36 Million -283.81 Million -217.66 Million -140.47 Million
Capital Lease Obligation 1.14 Million 3.65 Million 5.85 Million 5.95 Million 7.21 Million -
Total Investments 154.89 Million 111.61 Million 203.23 Million 190.45 Million 100.01 Million 46.62 Million
Total Debt 1.14 Million 3.65 Million 5.85 Million 5.95 Million 17.01 Million -
Net Debt -185.58 Million -122.08 Million -117.8 Million -111.39 Million -15.99 Million -82.23 Million

Balance Sheet Charts